NCT04673370

Brief Summary

In recent years, the number of people with symptoms of depression or anxiety are on the rise. The aims of the present study is to examine the effects of Ba Duan Jin on reducing symptoms of depression or anxiety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2019

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

December 8, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 17, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2024

Completed
Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

3.6 years

First QC Date

December 8, 2020

Last Update Submit

March 28, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • 17-item Hamilton Depression Rating Scale

    The HAMD-17 is a clinician-rated assessment (structured interview) of patients' depressive symptoms. Questions focus on depressive symptoms during the past 7 days, and higher cumulative scores indicate more severe depression.

    Change from Baseline HAMD-17 at 16 weeks

  • 14-item Hamilton Anxiety Rating Scale

    The HAMA-14 is a clinician-rated assessment (structured interview) of patients' anxious symptoms. Questions focus on anxious symptoms during the past 7 days, and higher cumulative scores indicate more severe anxiety.

    Change from Baseline HAMA-14 at 16 weeks

Secondary Outcomes (7)

  • Depression, Anxiety and Stress Scale-21 item

    Baseline

  • Depression, Anxiety and Stress Scale-21 item

    8 weeks

  • Depression, Anxiety and Stress Scale-21 item

    16 weeks

  • Gut microbiota

    Baseline

  • Gut microbiota

    16 weeks

  • +2 more secondary outcomes

Study Arms (2)

Ba Duan Jin Group

EXPERIMENTAL

Ba Duan Jin plus health education. Participants take part in 16-week program. The health education is conducted as the Health Education Group. Besides, the participants attended two 90-minute sessions of group-based Ba Duan Jin training per week and practiced at least three 30-minute Ba Duan Jin sessions at home per day.

Behavioral: Ba Duan Jin

Health Education Group

ACTIVE COMPARATOR

Health education. Participants take part in 16-week program. The health education includes work, rest, diet and other basic programs according to the different conditions of participants.

Behavioral: Health education

Interventions

Ba Duan JinBEHAVIORAL

Ba Duan Jin, a traditional Chinese health-preserving technique, combines techniques regulating body, breath and spirit. According to traditional Chinese theory, every movement of Ba Duan Jin has unique effect to different Zang-fu organs.

Also known as: Eight-section Brocade
Ba Duan Jin Group

Health education is provided by psychologist and TCM doctor, including work, rest, diet and other basic programs.

Health Education Group

Eligibility Criteria

Age18 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject with depression or anxiety symptom diagnosed by ICD-10.
  • Subject is male or female, age 18 to 75.
  • Subject has a clear mind and the ability to read, to talk and to communicate.
  • Subject agrees to participate in this study and sign to the informed consent

You may not qualify if:

  • Subject has severe somatic disease.
  • Subject has history of organic mental disorder, epilepsy, schizophrenia.
  • Subject takes any medication of food having effect on gut microbiota within 1 month of screening.
  • Subject has history of alcohol abuse.
  • Subject is pregnant, lactating or breast-feeding women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Qigong Research Institute

Shanghai, Shanghai Municipality, 021, China

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The study was a single-blind controlled trial in which the outcome assessor was blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A total of 60 patients were divided into a treatment group and a control group, with 30 cases in each group. The control group received health education,and the treatment group was treated with Ba Duan Jin plus health education program.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate

Study Record Dates

First Submitted

December 8, 2020

First Posted

December 17, 2020

Study Start

April 10, 2019

Primary Completion

October 31, 2022

Study Completion

February 4, 2024

Last Updated

April 2, 2025

Record last verified: 2025-03

Locations